![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 49, 34519-34522, December 3, 1999
From the Department of Pharmacology and Toxicology, University of
Louisville School of Medicine, Louisville, Kentucky 40292
Three novel human NAT2 alleles
(NAT2*5D, NAT2*6D, and NAT2*14G)
were identified and characterized in a yeast expression system. The
common rapid (NAT2*4) and slow (NAT2*5B)
acetylator human NAT2 alleles were also characterized for
comparison. The novel recombinant NAT2 allozymes catalyzed both
N- and O-acetyltransferase activities at levels
comparable with NAT2 5B and significantly below NAT2 4, suggesting that
they confer slow acetylation phenotype. In order to investigate the
molecular mechanism of slow acetylation in the novel NAT2
alleles, we assessed mRNA and protein expression levels and protein
stability. No differences were observed in NAT2 mRNA
expression among the novel alleles, NAT2*4 and
NAT2*5B. However NAT2 5B and NAT2 5D, but not NAT2 6D and
NAT2 14G protein expression were significantly lower than NAT2 4. In
contrast, NAT2 6D was slightly (3.4-fold) and NAT2 14G was
substantially (29-fold) less stable than NAT2 4. These results suggest
that the 341T
COMMUNICATION
Novel Human N-Acetyltransferase 2 Alleles That
Differ in Mechanism for Slow Acetylator Phenotype
C (Ile114
Thr) common to
the NAT2*5 cluster is sufficient for reduction in NAT2
protein expression, but that mechanisms for slow acetylator phenotype
differ for NAT2 alleles that do not contain 341T
C, such as the NAT2*6 and NAT2*14 clusters.
Different mechanisms for slow acetylator phenotype in humans are
consistent with multiple slow acetylator phenotypes.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Zang, M. A. Doll, S. Zhao, J. C. States, and D. W. Hein Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2 Carcinogenesis, August 1, 2007; 28(8): 1665 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kinzig-Schippers, D. Tomalik-Scharte, A. Jetter, B. Scheidel, V. Jakob, M. Rodamer, I. Cascorbi, O. Doroshyenko, F. Sorgel, and U. Fuhr Should We Use N-Acetyltransferase Type 2 Genotyping To Personalize Isoniazid Doses? Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1733 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Summerscales and P. D. Josephy Human Acetyl CoA:Arylamine N-Acetyltransferase Variants Generated by Random Mutagenesis Mol. Pharmacol., January 1, 2004; 65(1): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Fretland, U. S. Devanaboyina, M. A. Doll, S. Zhao, G. H. Xiao, and D. W. Hein Metabolic Activation of 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian Hamsters Congenic at the N-Acetyltransferase 2 (NAT2) Locus Toxicol. Sci., August 1, 2003; 74(2): 253 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Lee, K.-A Lee, C.-S. Ki, O. J. Kwon, H. J. Kim, M. P. Chung, G. Y. Suh, and J.-W. Kim Complete Sequencing of a Genetic Polymorphism in NAT2 in the Korean Population Clin. Chem., May 1, 2002; 48(5): 775 - 777. [Full Text] [PDF] |
||||
![]() |
C. Chen, S. Ricks, D. R. Doody, E.D. Fitzgibbons, P. L. Porter, and S. M. Schwartz N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk Carcinogenesis, December 1, 2001; 22(12): 1993 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sim, M. Payton, M. Noble, and R. Minchin An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes Hum. Mol. Genet., October 1, 2000; 9(16): 2435 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |